Morgan Stanley’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-473,973
Closed -$2.86M 6913
2019
Q4
$2.86M Buy
473,973
+111,253
+31% +$671K ﹤0.01% 3741
2019
Q3
$1.31M Sell
362,720
-468,677
-56% -$1.69M ﹤0.01% 4126
2019
Q2
$2.23M Buy
831,397
+760,761
+1,077% +$2.04M ﹤0.01% 3688
2019
Q1
$210K Sell
70,636
-224,772
-76% -$668K ﹤0.01% 5040
2018
Q4
$469K Buy
295,408
+53,450
+22% +$84.9K ﹤0.01% 4828
2018
Q3
$890K Sell
241,958
-81,131
-25% -$298K ﹤0.01% 4629
2018
Q2
$914K Sell
323,089
-1,433
-0.4% -$4.05K ﹤0.01% 4684
2018
Q1
$1.21M Sell
324,522
-4,486,067
-93% -$16.7M ﹤0.01% 4414
2017
Q4
$13.9M Buy
4,810,589
+4,294,088
+831% +$12.4M ﹤0.01% 2059
2017
Q3
$2.32M Buy
516,501
+216,525
+72% +$972K ﹤0.01% 3732
2017
Q2
$1.38M Sell
299,976
-1,614,927
-84% -$7.41M ﹤0.01% 4126
2017
Q1
$8.06M Sell
1,914,903
-475,929
-20% -$2M ﹤0.01% 2414
2016
Q4
$9.87M Buy
2,390,832
+2,027,775
+559% +$8.37M ﹤0.01% 2271
2016
Q3
$2.94M Buy
363,057
+246,308
+211% +$1.99M ﹤0.01% 3173
2016
Q2
$911K Buy
116,749
+77,980
+201% +$608K ﹤0.01% 4045
2016
Q1
$300K Sell
38,769
-194,452
-83% -$1.5M ﹤0.01% 4742
2015
Q4
$2.52M Buy
233,221
+205,405
+738% +$2.22M ﹤0.01% 3293
2015
Q3
$192K Sell
27,816
-95
-0.3% -$656 ﹤0.01% 5112
2015
Q2
$247K Sell
27,911
-896,148
-97% -$7.93M ﹤0.01% 5142
2015
Q1
$9.11M Buy
924,059
+890,381
+2,644% +$8.78M ﹤0.01% 2143
2014
Q4
$412K Sell
33,678
-168,119
-83% -$2.06M ﹤0.01% 4810
2014
Q3
$2.01M Sell
201,797
-773,848
-79% -$7.72M ﹤0.01% 3428
2014
Q2
$7.39M Buy
975,645
+365,844
+60% +$2.77M ﹤0.01% 2299
2014
Q1
$2.01M Sell
609,801
-159,709
-21% -$525K ﹤0.01% 3416
2013
Q4
$2.56M Buy
769,510
+605,323
+369% +$2.01M ﹤0.01% 3195
2013
Q3
$495K Sell
164,187
-87,490
-35% -$264K ﹤0.01% 4341
2013
Q2
$2.06M Buy
+251,677
New +$2.06M ﹤0.01% 3129